[HTML][HTML] Ethnopharmacological approaches for dementia therapy and significance of natural products and herbal drugs

D Tewari, AM Stankiewicz, A Mocan, AN Sah… - Frontiers in aging …, 2018 - frontiersin.org
Dementia is a clinical syndrome wherein gradual decline of mental and cognitive
capabilities of an afflicted person takes place. Dementia is associated with various risk …

Phyto-therapeutic and nanomedicinal approaches to cure Alzheimer's disease: present status and future opportunities

M Ovais, N Zia, I Ahmad, AT Khalil, A Raza… - Frontiers in aging …, 2018 - frontiersin.org
Alzheimer's disease (AD) is characterized by cognitive inability manifested due to the
accumulation of β-amyloid, formation of hyper phosphorylated neurofibrillary tangles, and a …

The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in vivo activity

U Kosak, B Brus, D Knez, S Zakelj… - Journal of medicinal …, 2018 - ACS Publications
The enzymatic activity of butyrylcholinesterase (BChE) in the brain increases with the
progression of Alzheimer's disease, thus classifying BChE as a promising drug target in …

Cholinesterase Inhibition Activity, Alkaloid Profiling and Molecular Docking of Chilean Rhodophiala (Amaryllidaceae)

LR Tallini, J Bastida, N Cortes, EH Osorio, C Theoduloz… - Molecules, 2018 - mdpi.com
Amaryllidaceae plants are the commercial source of galanthamine, an alkaloid approved for
the clinical treatment of Alzheimer's disease. The chemistry and bioactivity of Chilean …

Classics in chemical neuroscience: Donepezil

JT Brewster, S Dell'Acqua, DQ Thach… - ACS Chemical …, 2018 - ACS Publications
The discovery of acetylcholine and acetylcholinesterase provided the first insight into the
intricacies of chemical signal transduction and neuronal communication. Further elucidation …

Current therapeutic molecules and targets in neurodegenerative diseases based on in silico drug design

SA Sehgal, MA Hammad, RA Tahir… - Current …, 2018 - ingentaconnect.com
Background: As the number of elderly persons increases, neurodegenerative diseases are
becoming ubiquitous. There is currently a great need for knowledge concerning …

Synthesis and biological evaluation of new tetramethylpyrazine‐based chalcone derivatives as potential anti‐Alzheimer agents

M Wang, HL Qin, J Leng, Ameeduzzafar… - Chemical Biology & …, 2018 - Wiley Online Library
In the current study, a series of new ligustrazine‐based chalcones was synthesized. For
insertion of tetramethylpyrazine (TMP, also designated as ligustrazine) in chemical …

A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017

V Andrisano, M Naldi, A De Simone… - Expert opinion on …, 2018 - Taylor & Francis
ABSTRACT Introduction: Butyrylcholinesterase (BuChE) has obtained a renewed interest as
therapeutic target in Alzheimer's disease (AD), when changes in BuChE activity and …

Organoruthenium Prodrugs as a New Class of Cholinesterase and Glutathione‐S‐Transferase Inhibitors

S Ristovski, M Uzelac, J Kljun, T Lipec, M Uršič… - …, 2018 - Wiley Online Library
A small library of 17 organoruthenium compounds with the general formula [RuII
(fcl)(chel)(L)] n+ (in which fcl= face capping ligand, chel= chelating bidentate ligand, and L …

Novel donepezil-like N-benzylpyridinium salt derivatives as AChE inhibitors and their corresponding dihydropyridine “bio-oxidizable” prodrugs: Synthesis, biological …

R Azzouz, L Peauger, V Gembus, ML Ţînţaş… - European journal of …, 2018 - Elsevier
As an extension of our previous work on donepezil-based “bio-oxidizable” prodrug
approach, two new classes of N-benzylpyridinium donepezil analogues in tetralone B2 and …